CN Stock MarketDetailed Quotes

600223 Lushang Freda Pharmaceutical

Watchlist
  • 8.49
  • -0.12-1.39%
Not Open Dec 26 15:00 CST
8.63BMarket Cap36.44P/E (TTM)

Lushang Freda Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Lushang Freda Pharmaceutical Q3 2024 Earnings Date

Currency：CNYOct 29, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
877.19M
--
-4.82%
EPS
--
0.04
--
--
Analyst Rating
Strong Buy

Dec 26, 2024

Lushang Freda Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 4.852B--
--2024/FY-- / 4.221B--
Mar 22, 20242023/FY4.579B / 4.544B--
Mar 31, 20232022/FY12.951B / 12.040B--
--2021/FY12.363B / 15.184B--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 4.852B--
--2024/FY-- / 4.221B--
Mar 22, 20242023/FY4.579B / 4.544B--
Mar 31, 20232022/FY12.951B / 12.040B--
--2021/FY12.363B / 15.184B--

Unlock Free Earnings Estimates

Lushang Freda Pharmaceutical Earnings Reports

  • Freda: Report of Lushang Freda Pharmaceutical Co., Ltd. for the third quarter of 2024

    Oct 28 12:00 ET

  • Announcement of Lushang Freda Pharmaceutical Co., Ltd. on the main operating data for the third quarter of 2024

    Oct 28 12:00 ET

  • Lushang Freda Pharmaceutical Co., Ltd. Report for the Third Quarter of 2024

    Oct 28 12:00 ET

  • Lushang Freda Pharmaceutical Co., Ltd. 2024 Interim Report

    Aug 23 12:00 ET

    • Read more

    Top CN Stock Gainers
    Symbol Price % Chg
    Fangzheng Valve Group
    920082
    21.70 +518.23%
    PILOT
    831175
    19.05 +29.95%
    Kingsignal Technology
    300252
    12.28 +20.04%
    Jiangsu Yitong High-tech
    300211
    9.29 +20.03%
    Chengdu Qushui Science and Technology
    301336
    52.00 +20.01%

    See the daily top gainer.

    Analysis

    Analyst Rating

    Updated: Dec 26, 2024

    Strong Buy

    • Strong Buy

      68.75%

    • Buy

      31.25%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Investment Theme Tencent Concept
    Tencent Concept
    Intraday+1.69%